Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice

Lignende værker

• Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse
  af: Jackson, K. J., et al.
  Udgivet: (2010)
• Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
  af: Reed, Brian, et al.
  Udgivet: (2018)
• Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
  af: Reed, Brian, et al.
  Udgivet: (2018)
• Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human
  af: Rorick-Kehn, Linda M., et al.
  Udgivet: (2015)
• Development of Kappa Opioid Receptor Antagonists
  af: Carroll, F. Ivy, et al.
  Udgivet: (2013)